BioCompute Conference and Workshop

From BCOeditor Wiki
Jump to navigation Jump to search

2024 BioCompute Conference and Workshop

This workshop provides an opportunity to learn about interoperability between platforms that host BioCompute Objects (BCOs), the FDA’s "Portal" for reading, writing and sharing BCOs, real world applications including intended use in regulatory submissions, and potential implementations, including the use of AI/ML. This conference will have perspectives from both FDA and industry around the use of BioCompute in regulatory submissions, challenges for implementation, and tools designed to work with the standard. Join us for an in-depth discussion of BCO standards and an opportunity to view other projects during our poster session.

Event Registration: Eventbrite

Date & Time: May 10th, 2024, 9 AM - 5 PM

Location: Great Room, White Oak Campus, FDA center

Getting there

By Car

Enter "FDA Building 1" in Google Maps, then follow NW Loop Rd to the closest visitor parking, once reach the T-section turn right onto Michelson Rd to vehicle security screening before parking on the White Oak campus. FDA circulator shuttles are available between visitor parking and Building 1. Refer to the FDA website for the campus map.

By metro Public buses:

  • Ride On Bus Route 22 - stops at the Silver Spring (Red line) Metro station
  • BRT Flash Orange Route - stops at the Silver Spring (Red line) Metro station
  • Metro Bus C8 - stops at the White Flint (Red line), Glenmont (Red Line), and College Park (Green line) Metro stations
  • Metro Bus K6 - stops at the Fort Totten (Red, Green, and Yellow lines) Metro station
  • Metro Bus K9 - stops at the Fort Totten (Red, Green, and Yellow lines) Metro station

FDA shuttle to metro:

Please go to the FDA site for more transportation options.

Abstract

Documenting computational workflows has historically been a challenge for researchers and reviewers. Often, there are no clear guidelines for describing these workflows, leading to ad hoc definitions and descriptions that are insufficient for comprehension and reproducibility. BioCompute, an abbreviation for the IEEE standard 2791-2020, offers a structured framework for precisely yet adaptable describing workflows. A BioCompute Object (BCO) represents a workflow that adheres to this standard. This standard breaks down a workflow into its core components, aligning them with established data standards and ontologies. BioCompute significantly aids in streamlining workflow data, managing complexity across multiple versions, and enhancing reproducibility.

As the field evolves, addressing regulatory concerns becomes paramount, necessitating a common language for all stakeholders. The BioCompute community, comprised of over 400 individuals, has crafted a framework that offers guidance without imposing undue burdens on sponsors or reviewers. To date, BCO has been embraced by three FDA centers, effectively reducing delays in regulatory submissions. An ongoing pilot project involving the BioCompute team, FDA, and industry sponsors aims to improve communication efficiency and fluidity during submission and review processes.

The BioCompute Portal, the central platform for creating and submitting BCOs, has seen significant improvements in the past year, including Google and ORCID integration and an enhanced user interface. Furthermore, a new Portal instance at the FDA, along with four tools for authoring BCOs directly from various platforms (BCOnexus, Seven Bridges APP, the HIVE, and Galaxy platforms), and expanded documentation, make it easier to create, share, edit, and publish BCOs online. In addition, the FDA can retrieve BCOs from the public BCODB upon request, and with APIs and authentication tokens, users can directly submit to FDA portal API endpoints and interact with BCOs and their implementations seamlessly. All of the most up-to-date information about BioCompute will be introduced at the workshop and followed by a roundtable discussion to further improve the applicability of BioCompute from the FDA point of view and industry-wise.

Organization Committee

Jonathon Kenney (GWU/Chair); Raja Mazumder (GWU); Mark Walderhaug (FDA); Luis Santana-Quintero(FDA); Charles Hadley King (GWU); Omar Serang (DNAnexus); Sam Westreich (DNAnexus) Dennis A. Dean, II (Velsera); Phil Webster (Velsera); Kostis Karagiannis (Moderna)

Workshop Topics

  • Updates and future for BioCompute
  • Need for BCO at FDA
  • Considerations for Adoption in Industry
  • Progress Towards Usability
  • BCODB and Portal's use at the FDA
  • BCO platform interoperability
  • Exemplar workflows and real-world applications
  • BCO-Nextflow
  • Potential AI/ML-related implementations
  • FAQ session & Roundtable discussion

Poster Session

Participants are encouraged to submit a poster abstract by April 15th, 11:59 PM (EDT). Posters should describe a computational pipeline or topic related to BioCompute. Up to 5 posters will have their workflows converted into a BCO by the BCO team and published in the BCO Portal, and will be offered a 5-minute lightning talk at the end of the conference. All posters must be printed before the workshop and set up at the start of the event.

Abstract: Any computational workflow of interest, or topic related to BCOs

Poster Content: Posters should highlight or describe a workflow (either in progress or one already in use) and the way it is used.

Size: poster sizes can be up to 4' tall x 6' wide.

Submission Portal: click here.

Schedule

Time Speaker Affiliation and Title Content
9:00am - 10:00am Introduction and Future for BioCompute
9:00am - 9:10am Raja Mazumder Introduction
9:10am - 9:25am Jonathon Keeney Future of BioCompute
9:25am - 9:40am Vahan Simonyan BioCompute vision from an FDA-Industry perspective
9:25am - 10:00am Peter Marks Vision
10:00am - 11:00am Need for BCO at FDA
10:00am - 10:20am Mark Walderhaug Why BCO/RAB updates
10:20am - 10:35am Luis Santana-Quintero Computational Reviews at CBER
10:35am - 10:50am Eric Donaldson Perspectives from a Reviewer: High Throughput Sequencing Data Challenges in FDA Regulatory Review
10:50am - 11:00am Discussion
11:00am - 11:20am Break and poster review
11:20am - 12:15am Considerations for Adoption in Industry
11:20am - 11:35am Konstantinos Karagiannis Considerations to adoption at Moderna
11:35am - 11:50am UNCONFIRMED Considerations to adoption from industry
11:50am - 12:05pm UNCONFIRMED Considerations to adoption from industry
12:05pm - 12:15pm Discussion
12:15pm - 1:15pm Lunch & Poster Session
1:15pm - 4:10pm Progress Towards Usability
1:15pm - 1:30pm Susan Gregurick
1:30pm - 1:45pm Elaine Thompson BCO-CDISC: An emerging role for BioCompute: CDISC Standards for Cell and Gene Therapy Product (CGTP) Monitoring.
1:45pm - 2:00pm UNCONFIRMED ISO publication
2:00pm - 2:15pm Break and Poster review
2:15pm - 2:30pm RAB representative Forthcoming Guidance for BCO Submission
2:30pm - 2:50pm Dennis Dean Velsera
2:50pm - 3:05pm Sam Westreich DNAnexus: Democratizing access to BCOs with the BCOnexus Platform-Free Editor
3:05pm - 3:20pm Break and Poster review
3:20pm - 3:35pm UNCONFIRMED BCO-RO
3:35pm - 3:50pm Ben Sherman Nextflow-BCO
3:50pm - 4:05pm Konstantinos Krampis BCO in AI: Leveraging Large Language Models (aka ChatGPT) for Biocompute Object Generation in Bioinformatics
4:05pm - 4:30pm Break and Poster review
4:30pm - 5:00pm Lightning talk and closing
4:30pm - 4:45pm Chosen speakers Poster lightning talks
4:45pm - 5:00pm Closing

Confirmed Presenters

Sam Westreich.jpg
Konstantinos Krampis.jpg
Konstantinos Krampis
Elaine Thompson.jpg
Elaine E. Thompson, Ph.D.
Image001.png
Eric Donaldson
Jonathon Keeney.png
Raja Mazumder.png
Raja Mazumder
Charles Hadley King.png

Dennis A. Dean, II - Velsera

Phil Webster- Velsera

Omar Serang - DNAnexus

Contact Us

For questions about registration or general inquiries, please go to Contact Us

Event FAQs